RIL
REGN icon

Rothschild Investment LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Rothschild Investment LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$728K Sell
1,168
-318
-21% -$216K 0.03% 495
2026
Q1 		$1.15M Buy
1,486
+511
+52% +$391K 0.06% 247
2025
Q4 		$753K Buy
975
+366
+60% +$249K 0.04% 291
2025
Q3 		$342K Buy
609
+206
+51% +$116K 0.02% 444
2025
Q2 		$212K Buy
403
+3
+0.8% +$1.67K 0.01% 501
2025
Q1 		$254K Sell
400
-55
-12% -$37.8K 0.02% 450
2024
Q4 		$324K Sell
455
-85
-16% -$71.3K 0.02% 410
2024
Q3 		$568K Sell
540
-56
-9% -$62.3K 0.04% 322
2024
Q2 		$626K Buy
596
+83
+16% +$80.5K 0.04% 298
2024
Q1 		$494K Buy
513
+12
+2% +$11.4K 0.04% 327
2023
Q4 		$440K Buy
501
+27
+6% +$22.2K 0.04% 297
2023
Q3 		$390K Buy
474
+32
+7% +$25.1K 0.03% 336
2023
Q2 		$318K Buy
442
+24
+6% +$18.5K 0.03% 373
2023
Q1 		$343K Sell
418
-196
-32% -$148K 0.03% 350
2022
Q4 		$443K Sell
614
-56
-8% -$41.3K 0.04% 305
2022
Q3 		$462K Hold
670
– – 0.05% 290
2022
Q2 		$396K Hold
670
– – 0.04% 331
2022
Q1 		$468K Hold
670
– – 0.04% 336
2021
Q4 		$423K Hold
670
– – 0.03% 350
2021
Q3 		$405K Hold
670
– – 0.03% 345
2021
Q2 		$374K Sell
670
-250
-27% -$127K 0.03% 367
2021
Q1 		$435K Buy
920
+184
+25% +$89.6K 0.04% 339
2020
Q4 		$356K Hold
736
– – 0.03% 335
2020
Q3 		$412K Sell
736
-75
-9% -$45.5K 0.04% 287
2020
Q2 		$506K Hold
811
– – 0.06% 246
2020
Q1 		$396K Buy
811
+216
+36% +$89.1K 0.05% 271
2019
Q4 		$223K Buy
+595
New +$200K 0.02% 406

Other funds holding REGN

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Rothschild Investment LLC's REGN Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Regeneron Pharmaceuticals (REGN) stake by 21% in Q2 2026, selling an estimated $216K and leaving 1,168 shares worth $728K. The position accounts for 0.03% of the portfolio, ranked #495.

Rothschild Investment LLC first reported a position in REGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.15M in Q1 2026. 676 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Rothschild Investment LLC held 1,168 shares of Regeneron Pharmaceuticals worth $728K as of Q2 2026.
  • Rothschild Investment LLC sold 318 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $216K.
  • Regeneron Pharmaceuticals made up 0.03% of Rothschild Investment LLC's portfolio in Q2 2026, its #495 holding.
  • Rothschild Investment LLC first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • Rothschild Investment LLC's Regeneron Pharmaceuticals position peaked at $1.15M in Q1 2026.
  • 676 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.